Targeted Axillary Dissection Improves Axillary Evaluation following Neoadjuvant Chemotherapy in Node Positive Patients

被引：0
|
作者：
Caudle, A. S. [1 ]
Yang, W. [1 ]
Mittendorf, E. A. [1 ]
Black, D. M. [1 ]
Gilcrease, M. [1 ]
Bedrosian, I. [1 ]
Hobbs, B. P. [1 ]
Candelaria, R. P. [1 ]
Babiera, G. [1 ]
Dogan, B. E. [1 ]
Lim, M. J. [1 ]
Santiago, L. [1 ]
Hunt, K. K. [1 ]
Krishnamurthy, S. [1 ]
Kuerer, H. M. [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Surg Oncol, Houston, TX 77030 USA
来源：
ANNALS OF SURGICAL ONCOLOGY | 2015年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2
引用
收藏
页码：S6 / S6
页数：1
相关论文
共 50 条
  • [41] Evaluation of traditional targeted axillary dissection eligibility criteria for node-positive breast cancer after neoadjuvant chemotherapy in a prospective multicenter registry
    -Jones, Catherine Loveland
    Gaughan, John
    Caudle, Abigail
    Murphy, Brittany
    Samiian, Laila
    Byrum, Stephanie
    Brill, Kristen
    Germaine, Pauline
    Zhang, Xinmin
    Yoon-Flannery, Kay
    Carter, Teralyn
    Lopez, Adrian
    Gruner, Ryan
    Fantazzio, Michele
    Kuerer, Henry
    EJSO, 2024, 50 (04):
  • [42] Targeted axillary biopsy and sentinel lymph node biopsy for axillary restaging after neoadjuvant chemotherapy
    Gurleyik, Gunay
    Aksu, Sibel Aydin
    Aker, Fugen
    Tekyol, Kubra Kaytaz
    Tanrikulu, Eda
    Gurleyik, Emin
    ANNALS OF SURGICAL TREATMENT AND RESEARCH, 2021, 100 (06) : 305 - 312
  • [43] Omission of axillary dissection after neoadjuvant chemotherapy for node-positive primary breast cancer
    Matsumoto, A.
    Yasuko, U.
    Tsukahara, D.
    Jinno, H.
    EUROPEAN JOURNAL OF CANCER, 2020, 138 : S29 - S29
  • [44] Omission of Axillary Dissection Following Nodal Downstaging With Neoadjuvant Chemotherapy
    Montagna, Giacomo
    Mrdutt, Mary M.
    Sun, Susie X.
    Hlavin, Callie
    Diego, Emilia J.
    Wong, Stephanie M.
    Barrio, Andrea V.
    van den Bruele, Astrid Botty
    Cabioglu, Neslihan
    Sevilimedu, Varadan
    Rosenberger, Laura H.
    Hwang, E. Shelley
    Ingham, Abigail
    Papassotiropoulos, Baerbel
    Nguyen-Strauli, Bich Doan
    Kurzeder, Christian
    Aybar, Danilo Diaz
    Vorburger, Denise
    Matlac, Dieter Michael
    Ostapenko, Edvin
    Riedel, Fabian
    Fitzal, Florian
    Meani, Francesco
    Fick, Franziska
    Sagasser, Jacqueline
    Heil, Joerg
    Karanlik, Hasan
    Dedes, Konstantin J.
    Romics, Laszlo
    Banys-Paluchowski, Maggie
    Muslumanoglu, Mahmut
    Perez, Maria Del Rosario Cueva
    Diaz, Marcelo Chavez
    Heidinger, Martin
    Fehr, Mathias K.
    Reinisch, Mattea
    Tukenmez, Mustafa
    Maggi, Nadia
    Rocco, Nicola
    Ditsch, Nina
    Gentilini, Oreste Davide
    Paulinelli, Regis R.
    Zarhi, Sebastian Sole
    Kuemmel, Sherko
    Bruzas, Simona
    di Lascio, Simona
    Parissenti, Tamara K.
    Hoskin, Tanya L.
    Gueth, Uwe
    Ovalle, Valentina
    JAMA ONCOLOGY, 2024, 10 (06) : 793 - 798
  • [45] Axillary nodal management following neoadjuvant chemotherapy for node-positive breast cancer
    Ponce, Carolina
    Loza, Martin
    Mando, Pablo
    Pineiro, Africa
    Amat, Mora
    Costanzo, Victoria
    Nervo, Adrian
    Mysler, Daniel
    Nadal, Jorge
    Colo, Federico
    Loza, Jose
    Chacon, Reinaldo
    ANNALS OF SURGICAL ONCOLOGY, 2018, 25 : 437 - 438
  • [46] Axillary Management Following Neoadjuvant Chemotherapy in Clinically Node-Positive Breast Cancer
    Mitri, Samir
    Roldan-Vasquez, Estefania
    Flores, Rene
    Pardo, Jaime
    Borgonovo, Giulia
    Davis, Roger B.
    James, Ted A.
    CLINICAL BREAST CANCER, 2024, 24 (06) : 527 - 532
  • [47] Intraoperative Pathologic Evaluation with Targeted Axillary DissectionEditorial for “Intraoperative Touch Imprint Cytology in Targeted Axillary Dissection After Neoadjuvant Chemotherapy Among Breast Cancer Patients with Initial Axillary Metastasis”
    Abigail S. Caudle
    Annals of Surgical Oncology, 2018, 25 : 3112 - 3114
  • [48] Axillary lymph node dissection is not required for breast cancer patients with minimal axillary residual disease after neoadjuvant chemotherapy
    Muslumanoglu, Mahmut
    Mollavelioglu, Baran
    Cabioglu, Neslihan
    Emiroglu, Selman
    Tukenmez, Mustafa
    Karanlik, Hasan
    Ozmen, Tolga
    Yilmaz, Ravza
    Comert, Rana Gunoz
    Onder, Semen
    Bayram, Aysel
    Simsek, Duygu Has
    Oflas, Melis
    Ibis, Kamuran
    Aydiner, Adnan
    Ozmen, Vahit
    Igci, Abdullah
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2024, 22 (01)
  • [49] Can axillary lymph node dissection be avoided in patients with locally advanced breast cancer following neoadjuvant chemotherapy?
    Emirikci, S.
    Cabioglu, N.
    Trabulus, D.
    Ozkurt, E.
    Tukenmez, M.
    Dogan, S.
    Igci, A.
    Ozmen, V.
    Dinccag, A.
    Muslumanoglu, M.
    EUROPEAN JOURNAL OF CANCER, 2018, 92 : S85 - S85
  • [50] Axillary node management in patients receiving neoadjuvant chemotherapy
    Fernandez L.J.
    Bear H.D.
    Current Breast Cancer Reports, 2015, 7 (1) : 30 - 36
12345